Φορτώνει......
Protection from cigarette smoke‐induced vascular injury by recombinant human relaxin‐2 (serelaxin)
Smoking is regarded as a major risk factor for the development of cardiovascular diseases (CVD). This study investigates whether serelaxin (RLX, recombinant human relaxin‐2) endowed with promising therapeutic properties in CVD, can be credited of a protective effect against cigarette smoke (CS)‐indu...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | J Cell Mol Med |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
John Wiley and Sons Inc.
2016
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4831370/ https://ncbi.nlm.nih.gov/pubmed/26915460 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.12802 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|